PFSA Stock Analysis

Profusa, Inc. Common Stock
HEALTHCARE MEDICAL DEVICES

Back to Winners View Yahoo Finance Chart Buy on the Dip
Strong Caution Mixed Weak Unavailable
StockValueFinder Grade
D
47.44 / 100
Below Average
Confidence: High (86.0%) Coverage: 86.0%
Business Quality 60.1
Financial Strength 43.0
Earnings & Growth 37.4
Valuation 74.2
Market Strength 10.0
The grade combines Business Quality, Financial Strength, Earnings & Growth, Valuation, and Market Strength. Rating and Trend remain separate signals.
Rating AVOID
Avoid
The screening rules are warning against this setup.
Rating is the simple decision label from the screening rules.
Trend WEAK TREND
Unclear
Trend interpretation is unavailable.
Trend shows whether price action is helping or hurting the setup.
P/E Ratio 0.00
Value-Friendly
Below 15 is a classic value screen, but not proof of a bargain.
P/E shows how much investors pay for each dollar of earnings.
ROIC 302.48%
Strong
15%+ usually signals excellent capital efficiency.
ROIC measures how efficiently capital turns into profit.
Debt Payback -0.48 yrs
Unavailable
Debt payback is unavailable or not meaningful.
Debt payback estimates how quickly debt could be covered.
Interest Coverage -2.60x
Poor
Negative coverage means earnings are not covering interest costs.
Interest coverage shows how easily earnings cover interest costs.
Price $1.02
Market Price
Price alone is not a buy or sell signal.
Price should be judged with valuation, quality, and trend.
Last updated: 2026-10-22 20:30:47

Performance Overview

Trailing adjusted-close returns as of 2026-07-23. Benchmark is SPY.

YTD Return

PFSA -99.10%
SPY +8.83%

1-Year Return

PFSA -99.88%
SPY +17.68%

3-Year Return

PFSA N/A
SPY +69.45%

5-Year Return

PFSA N/A
SPY +79.56%

Returns are calculated from adjusted close prices and may differ from broker or research-site totals depending on data source, dividend handling, benchmark choice, and latest available trading date.

Legacy Screening Checks

This page uses cached SQL data from the latest StockValueFinder scan, so it loads fast without hitting Alpha Vantage on every page view.

57%
EPS Strength
FAIL

Looks for positive and improving earnings per share.

ROIC 10%+
PASS

Looks for strong return on invested capital.

Interest Coverage 6+
FAIL

Checks whether operating income comfortably covers interest expense.

Debt Payback ≤ 3 Years
PASS

Checks whether free cash flow could pay down long-term debt quickly.

P/E 15 or Less
PASS

Checks whether valuation is reasonable under the current rule set.

Moving Average Trend
WEAK TREND

Uses 20-day, 50-day, and 200-day moving averages for entry timing context.

A high StockValueFinder score is a research signal, not a guarantee. Strong companies can still fall during recessions, sector downturns, valuation resets, or company-specific events. Always review the business, risks, SEC filings, valuation, and your personal investment goals before buying.

Cached Technical Data

Moving average values from the latest stored scan.

20-Day MA1.45
50-Day MA3.08
200-Day MA1.36
MA Score2

Latest Published Stock Research

Research generated: October 22, 2026

PFSA Stock Analysis: Why Profusa, Inc. Common Stock Scored 57% in Stock Value Finder

Deep Dive Research: Evaluating Profusa, Inc. Common Stock (PFSA)

This article serves as a comprehensive educational review of Profusa, Inc. Common Stock (PFSA), conducted via the StockValueFinder methodology. The purpose of this research is to dissect the available financial metrics of PFSA to help investors understand how specific data points contribute to a stock's overall risk profile and quality assessment. This is not a recommendation to purchase or sell; rather, it is an analytical exercise designed to demonstrate how professional screening tools evaluate companies within the Healthcare/Medical Devices sector.

Overview of Profusa, Inc. Common Stock (PFSA)

Profusa, Inc. (Ticker: PFSA) operates within the Healthcare sector, specifically focusing on the Medical Devices industry. As of the most recent data provided for this analysis, the stock is trading at a price of $1.02.

In an era characterized by fluctuating interest rates and significant government debt levels, evaluating small-cap or micro-cap medical device companies requires a disciplined approach to fundamental analysis. Investors must distinguish between high-growth potential and the actual mathematical reality of a company's balance sheet. This report will break down PFSA through several critical lenses: profitability, capital efficiency, debt management, and valuation.

Why the StockValueFinder Score Matters

The StockValueFinder score for PFSA is 57%. Based on this quantitative assessment, the system has assigned a rating of **AVOID**.

It is important for students of the market to understand what a score represents. A StockValueFinder score is a composite metric that aggregates various financial tests, including earnings consistency, return on capital, debt obligations, and valuation discipline. A score of 57% indicates that while the company may pass certain isolated tests, it fails to meet the holistic requirements of a high-quality, low-risk investment.

In professional research, a "Pass" on one metric does not negate a "Fail" on another. For example, a company might have incredible efficiency (high ROIC) but be unable to cover its interest payments (low interest coverage). Such a discrepancy often signals structural instability. The "AVOID" rating is a cautionary signal generated when the mathematical weight of the failures outweighs the strength of the successes.

EPS Strength and Consistency

Earnings Per Share (EPS) is a fundamental metric used to determine how much profit a company makes for each outstanding share of common stock. Consistency in EPS is vital because it demonstrates a company's ability to generate repeatable, predictable value for shareholders.

In the case of Profusa, Inc., the system recorded an **EPS test result of "Did not pass."** While specific numerical EPS values were not supplied in this data set, the failure of the test indicates that the company did not meet the required threshold for earnings strength or consistency.

**Educational Note: How to Evaluate EPS** When analyzing other stocks, look for a history of stable or growing EPS. * **Strong Range:** A company that shows steady, incremental growth in EPS over several years is generally considered to have high quality. * **Weak Range:** A company with highly volatile EPS (swinging from large profits to large losses) or declining EPS suggests unpredictable business models or rising operational costs. * **Example:** If Company A earns $1.00 per share every year, and Company B earns $5.00 one year but loses $2.00 the next, Company A is often viewed as a more reliable entity for long-term planning.

ROIC and Capital Efficiency

Return on Invested Capital (ROIC) is one of the most critical metrics for assessing how effectively a management team uses the money provided by both debt holders and equity holders to generate profit.

Profusa, Inc. shows an exceptionally high **ROIC of 302.48%**. The system marked the ROIC test as **PASSED**.

**Educational Note: How to Evaluate ROIC** * **Strong Range:** StockValueFinder generally prefers an ROIC of 10% or higher. High ROIC suggests a "moat" or a significant competitive advantage that allows the company to generate massive returns from its assets. * **Weak Range:** An ROIC below 10% often suggests the company is struggling to generate meaningful value from its capital investments. * **Example:** A company with a 15% ROIC is using its capital significantly more efficiently than a company with a 4% ROIC. The 15% company is generating more "bang for its buck" for every dollar reinvested into the business.

While a 302.48% ROIC is mathematically impressive, researchers must always ask if such a number is sustainable or if it is a temporary result of a specific accounting period or a very small capital base.

Interest Coverage and Financial Safety

Interest coverage measures a company's ability to pay the interest on its outstanding debt. This is a vital "safety" metric, especially in environments where central banks may adjust interest rates, increasing the cost of borrowing.

For PFSA, the system recorded an **interest coverage test result of "Did not pass."**

**Educational Note: How to Evaluate Interest Coverage** * **Strong Range:** StockValueFinder prefers an interest coverage ratio of 6 or higher. This provides a significant "cushion" to ensure the company can meet its obligations even if earnings temporarily dip. * **Weak Range:** A ratio below 1.5 or 2 is often considered high-risk, as a small decline in operating income could leave the company unable to service its debt. * **Example:** An 8x coverage ratio is much healthier than a 2x coverage ratio. At 8x, the company earns eight times more than it needs to pay its interest; at 2x, there is very little room for error.

The failure of this test suggests that despite the high ROIC, PFSA may face significant liquidity risks regarding its debt obligations.

Debt Payback and Balance Sheet Discipline

Debt payback (often expressed in years) estimates how long it would take a company to pay back its total debt using its current cash flow or earnings. This metric measures the speed of deleveraging and overall balance sheet health.

Profusa, Inc. shows a **debt payback value of -0.48 years**. The system marked the debt payback test as **PASSED**.

**Educational Note: How to Evaluate Debt Payback** * **Strong Range:** StockValueFinder prefers a debt payback period of 3 years or less. * **Weak Range:** A debt payback period exceeding 7 or 10 years is often viewed as a sign of excessive leverage and long-term financial strain. * **Example:** A company that can clear its debt in 1.5 years is much more attractive from a risk-mitigation standpoint than one that requires 7 years of steady cash flow to reach the same goal.

A negative debt payback figure is a mathematical anomaly that typically occurs due to specific accounting treatments or cash positions; however, the system has categorized this as a "Pass" based on its internal logic.

P/E Ratio and Valuation Discipline

The Price-to-Earnings (P/E) ratio is a valuation metric that compares the current share price to its per-share earnings. It helps investors determine if they are overpaying for a company's current profits.

Profusa, Inc. has a **P/E ratio of 0.00**. The system marked the P/E valuation test as **PASSED**.

**Educational Note: How to Evaluate P/E** * **Strong Range:** StockValueFinder prefers a P/E of 15 or lower for strict valuation discipline. * **Weak Range:** Very high P/E ratios (e.g., 50, 100, or higher) can indicate that a stock is "expensive" relative to its current earnings, requiring massive future growth to justify the price. * **Example:** A P/E of 8 may be more value-oriented than a P/E of 40, assuming the underlying business quality is sound.

Note that a P/E of 0.00 often occurs when a company has no earnings or is reporting mathematical anomalies in its earnings calculation. While the system marked this as a "Pass" based on the threshold, it should be viewed with caution by any researcher.

Moving Average Trend and Entry Timing

Technical indicators like moving averages are used to identify the direction of a stock's price movement. This is intended for timing discipline, not as proof that a stock is fundamentally "good" or "bad."

The current signal for PFSA is a **WEAK TREND**. The entry signal is listed as **N/A**.

**Educational Note: How to Evaluate Trends** * **Trend Utility:** A moving average helps determine if a stock is in an uptrend or a downtrend. Investors use this to avoid "catching a falling knife" (buying a stock that is rapidly losing value). * **Entry Signals:** An "Entry Signal" or "Pullback Zone" provides a mathematical reference for where a trader might look to enter a position based on historical price patterns. * **Example:** If a stock is in a "Strong Uptrend," it means the price is consistently staying above its average. A "Weak Trend" suggests the price is moving sideways or lacks clear direction, increasing uncertainty.

Overall Financial Strengths and Weaknesses

When we aggregate the data for Profusa, Inc. (PFSA), a complex and contradictory picture emerges:

**Strengths:** * **Capital Efficiency:** The ROIC of 302.48% is extraordinarily high, suggesting that when the company uses capital, it generates massive returns. * **Valuation/Debt Metrics:** The system passed the P/E and Debt Payback tests, suggesting that on a purely mathematical basis regarding debt years and price-to-earnings thresholds, the company meets certain criteria.

**Weaknesses:** * **Earnings Reliability:** The failure of the EPS test indicates a lack of consistent, reliable earnings. * **Financial Safety:** The failure of the Interest Coverage test is a significant red flag, suggesting that despite high efficiency, the company may struggle to meet its interest obligations. * **Price Momentum:** The "Weak Trend" signal indicates a lack of upward momentum in the market.

Risks and Limitations

Investors must be aware that high-efficiency metrics (like ROIC) can sometimes mask underlying structural risks. In the medical device sector, companies often face high R&D costs and regulatory hurdles that can lead to volatile earnings. Furthermore, in an environment of currency instability and rising interest rates, companies that fail the "Interest Coverage" test are particularly vulnerable to increased borrowing costs.

Because PFSA is trading at a low price point of $1.02, it may be subject to higher volatility than larger-cap stocks. The lack of an "Entry Signal" or "Limit Buy Idea" means there is currently no mathematically defined "value zone" provided by the StockValueFinder system for this ticker.

Educational Conclusion

The analysis of Profusa, Inc. (PFSA) demonstrates why a multi-factor approach is necessary for sound research. A company can appear highly efficient (High ROIC) and pass valuation tests (P/E), yet still be categorized as an **AVOID** because it fails to provide consistent earnings (EPS) and lacks the ability to safely cover its debt obligations (Interest Coverage).

By studying these metrics, investors learn that quality is not found in a single number, but in the harmony between profitability, safety, and valuation.

This article is for research and educational purposes only. It is not personal financial advice, investment advice, or a recommendation to buy or sell any security.


Research links: Yahoo Finance | Seeking Alpha | Finviz | SEC Filings

Research Attribution
Mac Gemton IV

Mac Gemton IV is a financial research analyst specializing in equity valuation, ETF performance, dividend income strategies, and investment risk assessment. With a disciplined, data-driven approach, he examines company fundamentals, earnings growth, balance-sheet strength, valuation ratios, historical returns, and market trends. His research focuses on identifying financial strengths, potential risks, and long-term investment considerations, transforming complex financial data into clear, practical analysis for everyday investors.

30-Day Trendline Analysis

Optional intraday chart with rising support, falling resistance, and multi-timeframe views.

Load detailed price structure only when needed. Downloads roughly 30 days of 5-minute candles, identifies swing points, then calculates validated support and resistance lines.
Scroll to Top